ahlam1399
08-23-2016, 04:13 PM
BRIEF-Stemline Therapeutics expect to provide further updates around multiple SL-401
* Receives Breakthrough Therapy Designation From U.S. FoodAnd Drug Administration For SL-401http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=kZ_1Arlrnf0:IjaMa7dR0w8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=kZ_1Arlrnf0:IjaMa7dR0w8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=kZ_1Arlrnf0:IjaMa7dR0w8:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=kZ_1Arlrnf0:IjaMa7dR0w8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=kZ_1Arlrnf0:IjaMa7dR0w8:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/kZ_1Arlrnf0
* Receives Breakthrough Therapy Designation From U.S. FoodAnd Drug Administration For SL-401http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=kZ_1Arlrnf0:IjaMa7dR0w8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=kZ_1Arlrnf0:IjaMa7dR0w8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=kZ_1Arlrnf0:IjaMa7dR0w8:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=kZ_1Arlrnf0:IjaMa7dR0w8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=kZ_1Arlrnf0:IjaMa7dR0w8:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/kZ_1Arlrnf0